Elevated serum vascular endothelial growth factor is associated with visceral fat accumulation in human obese subjects

Diabetologia

Volumn 46, Issue 11, 2003, Pages 1483-1488

  Miyazawa Hoshimoto, S ^a   Takahashi, K ^a   Bujo, H ^a   Hashimoto, N ^a   Saito, Y ^a  

^a CHIBA UNIVERSITY   (Japan)

Author keywords

Adipose tissue; Body fat distribution; Computed tomography; Diet therapy; Vascular endothelial growth factor

Indexed keywords

ANGIOGENIC FACTOR; HEPARIN; SEPHAROSE; STROMELYSIN; TRANSCRIPTION FACTOR ETS 1; VASCULOTROPIN;

ABDOMINAL WALL; ADIPOSE TISSUE; ADULT; AGED; ARTICLE; BLOOD SAMPLING; BODY DISTRIBUTION; BODY FAT; BODY MASS; CARDIOVASCULAR DISEASE; CELL FUNCTION; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE ASSOCIATION; ENDOTHELIUM CELL; FEMALE; GENE EXPRESSION REGULATION; HUMAN; HUMAN CELL; LIPID STORAGE; MALE; METABOLIC DISORDER; OBESITY; PREDICTION; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PURIFICATION; REGRESSION ANALYSIS; SUBCUTANEOUS FAT; VASCULAR ENDOTHELIUM; WEIGHT REDUCTION;

ADIPOSE TISSUE; BASE SEQUENCE; BODY MASS INDEX; DNA PRIMERS; FEMALE; GENE EXPRESSION REGULATION; HOMEOSTASIS; HUMANS; INSULIN RESISTANCE; MALE; MATRIX METALLOPROTEINASE 3; MIDDLE AGED; OBESITY; PROTO-ONCOGENE PROTEIN C-ETS-1; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-ETS; REGRESSION ANALYSIS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SKIN; TOMOGRAPHY, X-RAY COMPUTED; TRANSCRIPTION FACTORS; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VISCERA;

EID: 0345117960     PISSN: 0012186X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00125-003-1221-6     Document Type: Article

References (31)

1. MacDougald OA, Hwang CS, Fan H, Lane MD (1995) Regulation of the obese gene product (Leptin) in white adipose tissue and 3T3 adipocytes. Proc Natl Acad Sci USA 92:9034-9037
2. Caro JF, Sinha MK, Kolaczynski JW, Zhang PL, Considine RV (1996) Leptin: the tale of an obesity gene. Diabetes 45:1455-1462
3. Hotamisligil GS, Shargill NS, Spiegelman BM (1993) Adipose expression of tumor necrosis factor-alpha: direct role in obesity-linked insulin resistance. Science 259:87-91
4. Shimomura I, Funahashi T, Takahashi M et al. (1996) Enhanced expression of PAI-1 in visceral fat: possible contributor to vascular disease in obesity. Nat Med 2:800-803
5. Mohamed-Ali V, Goodrick S, Rawesh A et al. (1997) Subcutaneous adipose tissue releases interleukin-6, but not tumor necrosis factor-alpha, in vivo. J Clin Endocr Metab 82:4196-4200
6. Bastard JP, Jardel C, Bruckert E et al. (2000) Elevated levels of interleukin 6 are reduced in serum and subcutaneous adipose tissue of obese women after weight loss. J Clin Endocrinol Metab 85:3338-3342
7. Maffei M, Halaas J, Ravussin E et al. (1995) Leptin levels in human and rodent: measurement of plasma leptin and ob RNA in obese and weight-reduced subjects. Nat Med 1:1155-1161
8. Considine RV, Sinha MK, Heiman ML et al. (1996) Serum immunoreactive-leptin concentrations in normal-weight and obese humans. N Engl J Med 334:292-295
9. Kern PA, Saghizadeh M, Ong JM, Bosch RJ, Deem R, Simsolo RB (1995) The expression of tumor necrosis factor in human adipose tissue. Regulation by obesity, weight loss, and relationship to lipoprotein lipase. J Clin Invest 95:2111-2119
10. Hotamisligil GS, Arner P, Caro JF, Atkinson RL, Spiegelman BM (1995) Increased adipose tissue expression of tumor necrosis factor-a in human obesity and insulin resistance. J Clin Invest 95:2409-2415
11. Dandona P, Weinstock R, Thusu K, Abdel-Rahman E, Aljada A, Wadden T (1998) Tumor necrosis factor-alpha in sera of obese patients: fall with weight loss. J Clin Endocrinol Metab 83:2907-2910
12. Cella F, Adami GF, Giordano G, Cordera R (1999) Effects of dietary restriction on serum leptin concentration in obese women. Int J Obes Relat Metab Disord 23:494-497
13. Wadden TA, Considine RV, Foster GD, Anderson DA, Sarwer DB, Caro JS (1998) Short- and long-term changes in serum leptin dieting obese women: effects of caloric restriction and weight loss. J Clin Endocrinol Metab 83:214-218
14. Kissebah AH, Vydelingum N, Murray R (1982) Relation of body fat distribution to metabolic complications of obesity. J Clin Endocrinol Metab 54:254-260
15. Hodge AM, Dowse GK, Zimmet PZ (1993) Association of body mass index and waist-hip circumference ratio with cardiovascular disease risk factors in Micronesian Nauruans. Int J Obes Relat Metab Disord 17:399-407
16. Tokunaga K, Matsuzawa Y, Ishikawa K (1983) A novel technique for the determination of body fat by computed tomography. Int J Obes 7:437-745
17. Suzuki R, Watanabe S, Hirai Y et al. (1993) Abdominal wall fat index, estimated by ultrasonography, for assessment of the ratio of visceral fat to subcutaneous fat in the abdomen. Am J Med 95:309-314
18. Matsuzawa Y, Funahashi T, Nakamura T (2002) Molecular mechanism of vascular disease in metabolic syndrome X. J Diabetes Complications 16:17-18
19. Shibasaki M, Takahashi K, Itou T et al. (2002) Alterations of insulin sensitivity by the implantation of 3T3-L1 cells in nude mice. A role for TNF-alpha? Diabetologia 45:518-526
20. Neufeld, G, Cohen T, Gengrinovitch S, Poltrak Z (1999) Vascular endothelial growth factor (VEGF) and its receptors. FASEB J 13:9-22
21. Claffey KP, Wilkison WO, Spiegelman BM (1992) Vascular endothelial growth factor: regulation by cell differentiation and activated second messenger pathways. J Biol Chem 267:16317-16322
22. Blann AD, Belgore FM, McCollum CN, Silverman S, Lip PL, Lip GY (2002) Vascular endothelial growth factor and its receptor, Flt-1, in the plasma of patients with coronary or peripheral atherosclerosis, or Type II diabetes. Clin Sci (Lond) 102:187-194
23. Sato Y, Abe M, Tanaka K et al. (2000) Signal transduction and transcriptional regulation of angiogenesis. Adv Exp Med Biol 476:109-115
24. Kobayashi J, Tashiro J, Murano S, Morisaki N, Saito Y. (1998) Lipoprotein lipase mass and activity in post-heparin plasma from subjects with intra-abdominal visceral fat accumulation. Clin Endocrinol 48:515-520
25. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC (1985) Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28:412-419
26. Emoto M, Nishizawa Y, Maekawa K et al. (1999) Homeostasis model assessment as a clinical index of insulin resistance in type 2 diabetic patients treated with sulfonylureas. Diabetes Care 22:818-822
27. Bonora E, Targher G, Alberiche M et al. (2000) Homeostasis model assessment closely mirrors the glucose clamp technique in the assessment of insulin sensitivity: studies in subjects with various degrees of glucose tolerance and insulin sensitivity. Diabetes Care 23:57-63
28. Stephan CC, Brock TA (1996) Vascular endothelial growth factor, a multifunctional polypeptide. PR Health Sci J 15:169-178
29. Ferrara N (2002) Links Role of vascular endothelial growth factor in physiologic and pathologic angiogenesis: therapeutic implications. Semin Oncol 29:10-14
30. Sreenath T, Matrisian LM, Stetler-Stevenson W, Gattoni-Celli S, Pozzatti RO (1992) Expression of matrix metalloproteinase genes in transformed rat cell lines of high and low metastatic potential. Cancer Res 52:4942-4947
31. Kanaki T, Bujo H, Mon S et al. (2002) Functional analysis of aortic endothelial cells expressing mutant PDGF receptors with respect to expression of matrix metalloproteinase-3. Biochem Biophys Res Commun 2002 294:231-237